Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-06-03 Sale | 2024-06-05 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,175 | $460 | $1,000,500 | 49,098 (Direct) | View |
2024-05-30 Sale | 2024-06-03 4:09 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,600 | $441.99 | $2,033,159 | 51,273 (Direct) | View |
2024-02-26 Sale | 2024-02-27 5:02 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 354 | $425.7 | $150,698 | 55,804 (Direct) | View |
2024-02-21 Sale | 2024-02-23 4:28 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 360 | $421.77 | $151,837 | 59,467 (Direct) | View |
2024-02-20 Sale | 2024-02-21 4:43 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 480 | $420.79 | $201,979 | 59,827 (Direct) | View |
2024-02-12 Sale | 2024-02-13 5:23 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 314 | $420.24 | $131,955 | 68,179 (Direct) | View |
2023-08-23 Sale | 2023-08-25 4:14 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,500 | $355 | $887,500 | 48,637 (Direct) | View |
2023-08-10 Sale | 2023-08-14 4:08 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 5,750 | $345.79 | $1,988,293 | 51,137 (Direct) | View |
2023-02-27 Sale | 2023-02-28 5:11 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 354 | $287.48 | $101,768 | 56,805 (Direct) | View |
2023-02-21 Sale | 2023-02-22 4:48 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 480 | $293.75 | $141,002 | 60,467 (Direct) | View |
2023-02-14 Sale | 2023-02-16 4:18 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 320 | $298.52 | $95,527 | 65,445 (Direct) | View |
2023-02-13 Sale | 2023-02-14 5:12 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 275 | $298.99 | $82,223 | 65,765 (Direct) | View |
2022-08-09 Sale | 2022-08-10 4:06 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,400 | $298.97 | $418,557 | 46,090 (Direct) | View |
2022-03-17 Sale | 2022-03-21 4:15 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,833 | $250.11 | $708,572 | 47,356 (Direct) | View |
2022-02-25 Sale | 2022-02-28 5:27 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 325 | $230.95 | $75,058 | 50,189 (Direct) | View |
2022-02-18 Sale | 2022-02-22 5:03 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 519 | $231 | $119,889 | 53,104 (Direct) | View |
2022-02-11 Sale | 2022-02-14 4:22 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 290 | $235.09 | $68,175 | 57,737 (Direct) | View |
2020-05-15 Sale | 2020-05-19 4:33 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer | 120 | $284 | $34,080 | 12,738 (Direct) | View |
2020-05-06 Sale | 2020-05-08 4:28 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer | 966 | $272.7 | $263,431 | 21,737 (Direct) | View |
2020-02-25 Sale | 2020-02-26 4:39 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 1,296 | $233.17 | $302,187 | 12,738 (Direct) | View |
2020-02-18 Sale | 2020-02-19 4:39 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 1,279 | $243.62 | $311,585 | 15,070 (Direct) | View |
2020-02-06 Sale | 2020-02-07 4:28 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 967 | $239.43 | $231,527 | 26,911 (Direct) | View |
2020-01-08 Sale | 2020-01-10 4:22 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 1,675 | $227.53 | $381,113 | 14,515 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | Tatsis Ourania Director | 267,541 | $0 | 267,541 (Direct) | View |
2024-02-23 Tax Withholding | 2024-02-27 5:02 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,309 | $431.79 | 55,804 (Direct) | View |
2024-02-16 Tax Withholding | 2024-02-21 4:43 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,499 | $424.01 | 59,827 (Direct) | View |
2024-02-20 Tax Withholding | 2024-02-21 4:43 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,373 | $420.58 | 59,827 (Direct) | View |
2024-02-09 Tax Withholding | 2024-02-13 5:23 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,100 | $422.74 | 68,179 (Direct) | View |
2024-02-06 Option Award | 2024-02-08 4:45 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 21,956 | $0 | 70,593 (Direct) | View |
2023-02-24 Tax Withholding | 2023-02-28 5:11 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 3,308 | $289.12 | 56,805 (Direct) | View |
2023-02-17 Tax Withholding | 2023-02-22 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,498 | $292.85 | 60,467 (Direct) | View |
2023-02-10 Tax Withholding | 2023-02-14 5:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,377 | $294.33 | 65,765 (Direct) | View |
2023-02-13 Tax Withholding | 2023-02-14 5:12 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,995 | $298.26 | 65,765 (Direct) | View |
2023-02-01 Option Award | 2023-02-03 5:01 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 24,322 | $0 | 70,412 (Direct) | View |
2022-02-24 Tax Withholding | 2022-02-28 5:27 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,590 | $227.86 | 50,189 (Direct) | View |
2022-02-17 Tax Withholding | 2022-02-22 5:03 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 4,114 | $232.51 | 53,104 (Direct) | View |
2022-02-10 Tax Withholding | 2022-02-14 4:22 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,230 | $237.74 | 57,737 (Direct) | View |
2022-02-01 Option Award | 2022-02-03 4:27 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 27,714 | $0 | 59,257 (Direct) | View |
2021-02-24 Tax Withholding | 2021-02-26 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,036 | $217.57 | 31,432 (Direct) | View |
2021-02-17 Tax Withholding | 2021-02-19 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,000 | $211.75 | 32,468 (Direct) | View |
2021-02-10 Tax Withholding | 2021-02-12 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 1,230 | $214.16 | 34,468 (Direct) | View |
2021-02-03 Option Award | 2021-02-05 4:59 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 22,960 | $0 | 35,698 (Direct) | View |
2020-05-06 Exercise | 2020-05-08 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer | 407 | $155.57 | 21,737 (Direct) | View |
2020-05-06 Exercise | 2020-05-08 4:28 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer | 966 | $0 | 21,737 (Direct) | View |
2020-05-06 Exercise | 2020-05-08 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Regulatory Officer | 559 | $187.53 | 21,737 (Direct) | View |
2020-02-24 Tax Withholding | 2020-02-26 4:39 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 1,036 | $239.23 | 12,738 (Direct) | View |
2020-02-17 Tax Withholding | 2020-02-19 4:39 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 597 | $241.5 | 15,070 (Direct) | View |
2020-02-06 Exercise | 2020-02-07 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 408 | $155.57 | 26,911 (Direct) | View |
2020-02-05 Option Award | 2020-02-07 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 9,694 | $0 | 26,911 (Direct) | View |
2020-02-06 Exercise | 2020-02-07 4:28 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 967 | $0 | 26,911 (Direct) | View |
2020-02-06 Exercise | 2020-02-07 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 559 | $187.53 | 26,911 (Direct) | View |
2020-01-08 Exercise | 2020-01-10 4:22 pm | N/A 2029-02-05 | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 1,675 | $0 | 14,515 (Direct) | View |
2020-01-08 Exercise | 2020-01-10 4:22 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania SVP, CRO | 1,675 | $187.53 | 14,515 (Direct) | View |